Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 09 April 2020
      #WeWontRest in the fight against COVID-19
 
 
  08 April 2020 Managing ongoing Clinical Trials in the current COVID-19 pandemic situation

It is of the utmost importance to strive as far as possible for a harmonised approach across all European countries...

Read more →
 
 
 
  08 April 2020 Official Update on the Connecting Healthcare Awards

A special COVID-19 category now available

Read more →
 
 
 
  07 April 2020 Indoors, but active and open more than ever to collaboration. From Italy, a story of ordinary...

Cittadinanzattiva highlights the ongoing collaborative efforts in Italy, where industry and civil society partners came...

Read more →
 
 
 
  03 April 2020 Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them...

EFPIA member companies are working around the clock to increase capacity and ensure supply of critical medicines to...

Read more →
 
 
 
      Videos
 
 
 
The European research-based pharmaceutical industry’s commitment to tackling COVID-19
EFPIA is the voice of the research-based pharmaceutical industry in Europe. As an industry #WeWontRest in fighting the COVID-19 pandemic. We are committed to working collaboratively across the research and healthcare communities, utilising our world-leading science, people and resources to tackle this outbreak.
 
 
#WeWontRest in the fight against COVID 19
As the impact of COVID-19 continues to be felt across the world, the biopharmaceutical industry in Europe remains committed to global efforts to care for those affected, contain the outbreak and develop resources to tackle future outbreaks.
 
 
 
 
 
EFPIA members' efforts against COVID-19: a story from Pfizer Italy
Paivi Kerkola, Pfizer country manager Italy, explains how they are supporting Italian regions impacted by this pandemic.
 
 
IMI: Carrying the torch for medical innovation
Diseases keep changing, and infections we treated for decades can once again kill. By bringing together researchers from the public and private sectors, we are working to speed up medicines development and turn knowledge into treatments.
 
 
 
 
      Events
 
 
20 APR 2020
  Europe COVID-19 battle: The pharmaceutical industry response Virtual event

With Europe at the epicentre of the COVID-19 pandemic, we want to give partners and health stakeholders around Europe...

Learn more →
 
 
 
20 APR 2020
  COVID-19 Virtual Partnering Virtual event

In normal times, thousands of organizations would gather in a large conference center to meet and exchange. Clearly...

Learn more →
 
 
 
14 MAY 2020
  10th European Conference on Rare Diseases & Orphan Products Virtual event

The upcoming ECRD 2020 will be held 100% online!

Learn more →
 
 
 
26 OCT 2020
  NEW DATES - EU Health Summit 2020 Virtual event

The EU Health Coalition is delighted to announce the second edition of the EU Health Summit.

Learn more →
 
 
      Other resources
Open Memo to the Health Industry 09 April 2020  (European Patients Forum) Read more →
Health System Response Monitor 02 April 2020  (WHO Europe) Read more →
Global AMR R&D Hub’s Dynamic Dashboard 01 April 2020  (Global AMR R&D Hub) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe